577 related articles for article (PubMed ID: 15579802)
1. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.
Hammer GD; Tyrrell JB; Lamborn KR; Applebury CB; Hannegan ET; Bell S; Rahl R; Lu A; Wilson CB
J Clin Endocrinol Metab; 2004 Dec; 89(12):6348-57. PubMed ID: 15579802
[TBL] [Abstract][Full Text] [Related]
2. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
[TBL] [Abstract][Full Text] [Related]
3. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB; Turner HE; Adams CB; Wass JA
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[TBL] [Abstract][Full Text] [Related]
4. Repeat transsphenoidal surgery for Cushing's disease.
Friedman RB; Oldfield EH; Nieman LK; Chrousos GP; Doppman JL; Cutler GB; Loriaux DL
J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
[TBL] [Abstract][Full Text] [Related]
5. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
[TBL] [Abstract][Full Text] [Related]
7. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
8. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
[TBL] [Abstract][Full Text] [Related]
9. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
10. Does an analysis of the pulsatile secretion pattern of adrenocorticotropin and cortisol predict the result of transsphenoidal surgery in Cushing's disease?
Buchfelder M; Fahlbusch R; Wentzlaff-Eggebert H; Brabant G; Stalla GK; Müller OA
J Clin Endocrinol Metab; 1993 Sep; 77(3):720-4. PubMed ID: 8396575
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
Bakiri F; Tatai S; Aouali R; Semrouni M; Derome P; Chitour F; Benmiloud M
J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739
[TBL] [Abstract][Full Text] [Related]
12. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.
Chen JC; Amar AP; Choi S; Singer P; Couldwell WT; Weiss MH
J Neurosurg; 2003 May; 98(5):967-73. PubMed ID: 12744355
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and long-term outcome in pituitary-dependent Cushing's disease.
Sonino N; Zielezny M; Fava GA; Fallo F; Boscaro M
J Clin Endocrinol Metab; 1996 Jul; 81(7):2647-52. PubMed ID: 8675592
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group.
Bochicchio D; Losa M; Buchfelder M
J Clin Endocrinol Metab; 1995 Nov; 80(11):3114-20. PubMed ID: 7593411
[TBL] [Abstract][Full Text] [Related]
15. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
Imaki T; Tsushima T; Hizuka N; Odagiri E; Murata Y; Suda T; Takano K
Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
[TBL] [Abstract][Full Text] [Related]
16. Cushing's disease resulting from pituitary corticotrophic microadenoma. Treatment results from transsphenoidal microsurgery and gamma knife radiosurgery.
Laws ER; Reitmeyer M; Thapar K; Vance ML
Neurochirurgie; 2002 May; 48(2-3 Pt 2):294-9. PubMed ID: 12058134
[TBL] [Abstract][Full Text] [Related]
17. Intracavernous sinus ectopic adrenocorticotropin-secreting tumours causing therapeutic failure in transsphenoidal surgery for Cushing's disease.
Ohnishi T; Arita N; Yoshimine T; Mori S
Acta Neurochir (Wien); 2000; 142(8):855-64. PubMed ID: 11086823
[TBL] [Abstract][Full Text] [Related]
18. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients.
Shimon I; Ram Z; Cohen ZR; Hadani M
Neurosurgery; 2002 Jul; 51(1):57-61; discussion 61-2. PubMed ID: 12182435
[TBL] [Abstract][Full Text] [Related]
19. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.
Patil CG; Prevedello DM; Lad SP; Vance ML; Thorner MO; Katznelson L; Laws ER
J Clin Endocrinol Metab; 2008 Feb; 93(2):358-62. PubMed ID: 18056770
[TBL] [Abstract][Full Text] [Related]
20. Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood.
Leinung MC; Kane LA; Scheithauer BW; Carpenter PC; Laws ER; Zimmerman D
J Clin Endocrinol Metab; 1995 Aug; 80(8):2475-9. PubMed ID: 7629245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]